ICE-HBV just published an article in Science Translational Medicine with Matteo Iannacone as lead author that reviews RNA-targeting drugs in development for HBV. This paper grew out of the 2023 ICE-HBV Symposium in Kobe, Japan.
Click here to access the paper
Image modified from S. Foti, in Comprehensive Pharmacology, 2022
Robert1.28.2.5 Antisense oligonucleotide and siRNA therapeutics